[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4834 followers Created: 2025-03-12 06:03:02 UTC BINGO! $RHHBY enters into an exclusive collaboration & licensing agreement with $ZEAL to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity. $1.65B upfront! #Amylin $GUBRA $NVO  XXXXXX engagements  **Related Topics** [abbv](/topic/abbv) [$gubra](/topic/$gubra) [$165b](/topic/$165b) [$zeal](/topic/$zeal) [$rhhby](/topic/$rhhby) [$nvo](/topic/$nvo) [stocks healthcare](/topic/stocks-healthcare) [$abbv](/topic/$abbv) [Post Link](https://x.com/doepke_michel/status/1899702655242420464)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Michel Doepke @doepke_michel on x 4834 followers
Created: 2025-03-12 06:03:02 UTC
BINGO! $RHHBY enters into an exclusive collaboration & licensing agreement with $ZEAL to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity. $1.65B upfront! #Amylin $GUBRA $NVO
XXXXXX engagements
Related Topics abbv $gubra $165b $zeal $rhhby $nvo stocks healthcare $abbv
/post/tweet::1899702655242420464